New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 23, 2013
17:11 EDTSUPN, UTHRSupernus announces FDA approval of Orenitram
Supernus Pharmaceuticals (SUPN) announced that the FDA approved Orenitram Extended-Release Tablets for the treatment of pulmonary arterial hypertension in WHO Group I patients to improve exercise capacity. Supernus developed the extended release formulation of Orenitram under a Development and License Agreement with United Therapeutics (UTHR). The product uses EnSoTrol, Supernus' novel osmotic technology platform. Per the license agreement between Supernus and United Therapeutics, United Therapeutics will pay Supernus certain milestone fees and royalties associated with the commercialization of the product worldwide.
News For SUPN;UTHR From The Last 14 Days
Check below for free stories on SUPN;UTHR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 10, 2014
07:24 EDTUTHRInternational Society for Heart & Lung Transplantation to hold annual meeting
Subscribe for More Information
April 8, 2014
07:22 EDTUTHRCaSA-ISPE to hold a conference
21st Annual Lilfe Sciences Technology Conference is being held in Raleigh, North Carolina on April 8.
April 7, 2014
11:17 EDTUTHRUnited Therapeutics upgraded to Buy from Hold at Standpoint Research
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use